text:
IPRoyal.com/Blog
Pawns (2)
How to Earn the Most Money With the IPRoyal Pawns Affiliate Program
New IPRoyal Pawns Application Released
We are proud to announce we just released the newest version of the IPRoyal Pawns app. Since the beginning of IPRoyal Pawns, many people have asked for specific features. We're working hard to expand the functionality, incorporate the most requested features, and expand to new platforms.
What's New in the Latest Version of the IPRoyal Pawns App
This particular update focuses on connectivity and convenience. We included some significant functions that we're sure our users will love. The original idea behind this update was to make the application work with as little hassle as possible. We believe we succeeded in achieving that goal. As always, you can get the latest version from your Pawns Dashboard. Let's have a look at the key features!
Smart Connectivity Functions
The new and improved IPRoyal Pawns app just became a lot more intelligent both on Windows and macOS. A lot of our users have been complaining about certain things in the past months like random crashes, dropped connection, no sleep support, etc. Well, we're proud to sy that all of these problems just became history.
The new version will now try to reconnect automatically whenever your internet connection resets for whatever reason. When your computer wakes up from sleep, you won't have to restart the app to get it to reconnect. If your internet connection gets interrupted, the app will keep trying to reconnect until it manages to do so. The same goes for any issues on our end.
These intelligent features will be particularly helpful for people who leave the app running on their PC when they're not around or in similar scenarios. Some of our users leave their PCs running overnight. Others install the app on their file or media servers and similar machines. You can now let the app run for days (or months!) without checking every couple of hours to make sure it works properly.
Automatic Startup with Windows
This is another feature a lot of our users have been asking for. The IPRoyal Pawns app now starts automatically every time you turn on your PC. There's a new toggle in the installer, so make sure to turn it off if you want to keep running the app manually.
Many people just don't remember to turn it on, so we believe this feature will be helpful for every Forgetful Freddies out there. Keep in mind the IPRoyal Pawns app is a constant work in progress, so this feature only works on Windows computers at the moment.
How to Prevent Automatic Startup
Speaking of work in progress, while we made the app run automatically on startup, we have yet to include an option to prevent it from starting automatically. We're aware that this behavior is not ideal for every single user. If you just breezed through the installer and left the "Start on login" feature turned on, you can reinstall the app and turn it off.
In case you don't want to reinstall the app, you can prevent it from starting automatically in a few simple steps:
1. Open your Task Manager
Type "task" on your Start Screen. The Task Manager will show up on the list. Select it and press Enter. You can also use the shortcut Ctrl+Shift+Esc or Ctrl+Alt+Delete (and then select Task Manager from the list).
2. Switch to the "Startup" tab
Here you'll see all applications that start every time you turn on your PC. Find the "iproyal_pawns.exe" entry and left-click on it.
3. Select "Disable" from the menu
By doing this, you ensure the app doesn't start with Windows. If you want to remove the startup entry from Task Manager, just uninstall the IPRoyal Pawns app, and it will disappear. Right-click on your IPRoyal Pawns app icon on your desktop and select "Open File Location". In the window that opens, locate the uninstaller, run it, and that's it! Now you can reinstall the app and make sure "Start on login" is unchecked.
We hope these new features will make your experience with the IPRoyal Pawns app more convenient, carefree, and lucrative. As always, keep an eye out for any news on future updates via Discord, Twitter, and Facebook!


text:
Home / Brooks Glycerin GTS 20 / Reviews & News
Brooks Glycerin GTS 20
By Running Lab Staff
Posted in Brooks, Glycerin GTS, stability, Support
The brand-new Brooks Glycerin GTS 20 includes tons of fun changes to the familiar high-cushion shoe. In this update to the Glycerin line, Brooks combines their GuideRails technology, meant to keep runners stable and supported underfoot, with a soft, nitrogen-injected DNA LOFT v3 midsole.
A more accommodating fit and a comfortable mesh upper give this new model a wonderful ride for walkers and runners alike. It's perfectly built for casual walks and long, easy runs. See what our wear tester, Blake, has to say about the Glycerin GTS 20!
SUPPORT: High Cushion Stability
STACK HEIGHT: 38mm (heel), 28mm (forefoot)
HEEL TO TOE OFFSET: 10mm
WEIGHT: 9.4oz (266.5g) women's / 10.5oz (297.7g) men's
USE: Everyday running, walking
SURFACE: Road, track, urban
Blake: Running in this shoe felt super comfortable. Every step, I felt that I was able to bounce off the ground easily and it didn't take away too much of the impact of the ground. I honestly spent more time in the shoe standing and working in it. I would recommend this shoe to anyone looking for a supportive pair of shoes to work in. I forgot that I was wearing shoes a lot of the time when running and working in these shoes.
Blake: The cushioning is unreal. It is so responsive and supportive that I honestly forget that I am wearing a shoe. It's super light as well which makes having a high-quality cushion feel like you are almost not even walking or running in the shoe. For a high cushion shoe, it is super light compared to previous models and its competitors. And even though there is so much squish in the foam of the shoe, it does not feel that it takes any force away from your stride.
Blake: Just like other stability-oriented Brooks shoes, a GuideRails system is present which creates stability and support. Like previous models, it is the perfect blend between controlling the foot's motion but still allowing the body's natural movement. Each side of the GuideRails will bring you back to a more neutral alignment with ease. This makes it feel as if the shoe moves to support the foot wherever the body's motion is lacking.
Blake: The toebox has the perfect amount of room! Especially compared to previous models, the upper has just the right amount of space to not feel too condensed. The fit of the midfoot feels so comfortable. There is just the right amount of space on each side of the foot and the sole makes it feel like you are being cradled with foam. The heel cup is a great blend of holding your foot in place while not squeezing it. There is no slippage and it is fairly easy to get on and off. The length feels perfect! It runs true to size when compared to most other Brooks shoes and is not nearly as tight as the previous version of this shoe. The tongue is nice but it does tend to lean to the outside of the shoe rather than staying in place. It is fairly light and is not too dense, which makes it feel like it's not even there. Even if it doesn't stay in the same spot, it's hardly noticeable. The upper is super breathable while also being stretchier than any previous model of the Glycerin.
Blake: I would recommend almost every run other than speed workouts for the new Glycerin. The cushion provides enough support that it will make every step feel supported. But unlike other high cushion shoes where the shoe feels that it takes the impact away, the shoe feels usable for almost every single run. Regardless, it may still make speed workouts a little bit harder by virtue of having a thicker sole and a squishier ride.
Blake: The Glycerin feels lighter than its competitors. The way the nitrogen reacts to the DNA loft in this pair of Glycerin feels like it takes just the right amount of impact away where the runner will still feel the ground. In other options like the New Balance 1080 or the Nike Invincible Run, the shoe doesn't feel like it conforms to the foot as comfortably as the Glycerin. The stack height of these competitors also feels so high that you are on a platform, whereas the Glycerin feels like it has much better ground contact. The Glycerin feels perfect because it sits in the sweet spot of having a high amount of cushion without feeling too elevated.
Blake: The newest pair of Glycerin GTS 20 feel unrecognizable from the previous pairs. Not only is there finally enough comfort and space in the toe box of the shoe, but the new nitrogen-injected DNA LOFT v3 provides a much softer response to the ground. Previous models felt fairly dense and firm; this newest pair gives the perfect amount of impact reduction from ground. I would consider this a vast improvement on the formula of the Glycerin but fans of the previous model may be put off by the changes that were made. I can only imagine this would happen if someone thought the new Glycerin was too soft.
Blake: This shoe is for runners, walkers, workers, and anyone who has feet. As a running shoe, it feels a perfect blend between not being too cushioned and still taking some of the impact away from striking the ground. For people looking for a shoe to walk, work, or stand in, this is amazing as well. The foam makes the body feel energized and supported and at times you will forget that you are wearing a shoe. I would wholeheartedly recommend this shoe to everyone and anyone who is looking for that perfect supportive, high cushion shoe.
MEET YOUR REVIEWERS
Wears men's size 9.5
I work at the Running Lab and love to run around Brighton! I just completed my first half marathon this year and will continue to enjoy doing more races and events in the future. I am not a long-time runner but a shoe geek. I love everything about shoes and running in them gives me a newfound respect and perspective on footwear!
Be the first to comment...
* Your email address will not be published
Saucony Endorphin Shift 3
New Balance FuelCell SuperComp Pacer
Saucony Ride 15
Altra Vanish Carbon
Endorphin Shift (1)
Glycerin (1)
Glycerin 20 (1)
Glycerin GTS (1)
High Cushion (10)
Kinvara 13 (1)
mid cushion (6)
Road running (4)
smartwool (1)
Topo (3)
Running Lab scores a 5.0/5 out of 209 reviews at

redpajama_set_name: RedPajamaCommonCrawl


text:
ATLANTA: 1800 Howell Mill Rd • Suite 800 • Atlanta, GA 30318 • 404-350-9853
FAYETTEVILLE: 1267 Highway 54 West • Suite 4200 • Fayetteville, GA 30214 • 678-829-1060
NEWNAN: 775 Poplar Rd. • Suite 310 • Newnan, GA 30265 • 770-251-2590
HENRY: 1240 Eagles Landing Parkway • Suite 260 • Stockbridge, GA 30281 • 678-854-9500
Refer a Patient Second Opinion Telehealth Bill Pay Patient Portal Call Us
Atlanta: 404-350-9853
Fayetteville: 678-829-1060
Newnan: 770-251-2590
Stockbridge: 678-854-9500
Sandy Springs: Coming 2022!
Connect with PCI
All Physicians
Nikita Amin, MD
Vasily Assikis, MD
Jonathan Bender, MD
Trevor Feinstein, MD
William Jonas, MD
Vipin Lohiya, MD
Eric Mininberg, MD
Minesh Patel, MD
Jay Rhee, MD
Samantha Shams, MD
Rajni Sinha, MD, MRCP
Ha Tran, MD
Physicians Emeritus
Laura Beals, MSN, AGPCNP-BC
Danielle Bowen, MMSc, PA-C
Stephanie Braatz, MSN, NP-C, AOCNP
Jillian Brooks, DNP, FNP-C
Chelsea Collins, MSN, NP-C
Scott Helms, MMSc, PA-C
Charles Hortenstine, MSM, PA-C
Kathryn Parr, MSN, NP-C
Anna Robinson, MSN, ACNP-BC
Mary Ryan, MSN, NP-C
Julieta Valenzona, MSN, NP-C
Amanda Woodward, MSN, FNP-C, OCN
Amy York, MMSc, PA-C
Personalized Care
Medical Oncology & Hematology
Current Clinical Trials
Telehealth Visits
Patient Engagement Portal
Notice of Data Security Incident
Sandy Springs - Coming 2022
Our Pharmacy
After Hours & Emergencies
Home Our Specialty, Medical Oncology & Hematology Cancers We Treat Prostate Cancer
General Information About Prostate Cancer
Key Points for This Section
Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.
Possible signs of prostate cancer include a weak flow of urine or frequent urination.
Tests that examine the prostate and blood are used to detect (find) and diagnose prostate cancer.
Certain factors affect prognosis (chance of recovery) and treatment options.
The prostate is a gland in the male reproductive system located just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine). It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from the bladder). The prostate gland produces fluid that makes up part of the semen.
Prostate cancer is found mainly in older men. As men age, the prostate may get bigger and block the urethra or bladder. This may cause difficulty in urination or can interfere with sexual function. The condition is called benign prostatic hyperplasia (BPH), and although it is not cancer, surgery may be needed to correct it. The symptoms of benign prostatic hyperplasia or of other problems in the prostate may be similar to symptoms of prostate cancer.
These and other symptoms may be caused by prostate cancer. Other conditions may cause the same symptoms. A doctor should be consulted if any of the following problems occur:
Weak or interrupted flow of urine.
Frequent urination (especially at night).
Trouble urinating.
Pain or burning during urination.
Blood in the urine or semen.
A pain in the back, hips, or pelvis that doesn't go away.
Painful ejaculation.
The following tests and procedures may be used:
Digital rectal exam (DRE): An exam of the rectum. The doctor or nurse inserts a lubricated, gloved finger into the rectum and feels the prostate through the rectal wall for lumps or abnormal areas.
Transrectal ultrasound: A procedure in which a probe that is about the size of a finger is inserted into the rectum to check the prostate. The probe is used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. Transrectal ultrasound may be used during a biopsy procedure.
Biopsy: The removal of cells or tissues so they can be viewed under a microscope by a pathologist. The pathologist will examine the biopsy sample to check for cancer cells and determine the Gleason score. The Gleason score ranges from 2-10 and describes how likely it is that a tumor will spread. The lower the number, the less likely the tumor is to spread. There are 2 types of biopsy procedures used to diagnose prostate cancer:
Transrectal biopsy: The removal of tissue from the prostate by inserting a thin needle through the rectum and into the prostate. This procedure is usually done using transrectal ultrasound to help guide the needle. A pathologist views the tissue under a microscope to look for cancer cells.
Transperineal biopsy: The removal of tissue from the prostate by inserting a thin needle through the skin between the scrotum and rectum and into the prostate. A pathologist views the tissue under a microscope to look for cancer cells.
The prognosis (chance of recovery) and treatment options depend on the following:
The stage of the cancer (whether it affects part of the prostate, involves the whole prostate, or has spread to other places in the body).
The patient's age and health.
Whether the cancer has just been diagnosed or has recurred (come back).
Prognosis also depends on the Gleason score and the level of PSA.
Stages of Prostate Cancer
After prostate cancer has been diagnosed, tests are done to find out if cancer cells have spread within the prostate or to other parts of the body.
There are three ways that cancer spreads in the body.
The following stages are used for prostate cancer:
Stage II
The process used to find out if cancer has spread within the prostate or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. The following tests and procedures may be used in the staging process:
Radionuclide bone scan: A procedure to check if there are rapidly dividing cells, such as cancer cells, in the bone. A very small amount of radioactive material is injected into a vein and travels through the bloodstream. The radioactive material collects in the bones and is detected by a scanner.
MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).
Pelvic lymphadenectomy: A surgical procedure to remove the lymph nodes in the pelvis. A pathologist views the tissue under a microscope to look for cancer cells.
CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.
Seminal vesicle biopsy: The removal of fluid from the seminal vesicles (glands that produce semen) using a needle. A pathologist views the fluid under a microscope to look for cancer cells.
The stage of the cancer is based on the results of the staging and diagnostic tests, including the prostate specific antigen (PSA) test and the original tumor biopsy. The biopsy is used to determine the Gleason score. The Gleason score ranges from 2-10 and describes how different the cancer cells look from normal cells and how likely it is that the tumor will spread. The lower the number, the less likely the tumor is to spread.
The three ways that cancer spreads in the body are:
Through tissue. Cancer invades the surrounding normal tissue.
Through the lymph system. Cancer invades the lymph system and travels through the lymph vessels to other places in the body.
Through the blood. Cancer invades the veins and capillaries and travels through the blood to other places in the body.
When cancer cells break away from the primary (original) tumor and travel through the lymph or blood to other places in the body, another (secondary) tumor may form. This process is called metastasis. The secondary (metastatic) tumor is the same type of cancer as the primary tumor. For example, if breast cancer spreads to the bones, the cancer cells in the bones are actually breast cancer cells. The disease is metastatic breast cancer, not bone cancer.
In stage I, cancer is found in the prostate only. The cancer:
is found by needle biopsy (such as for a high PSA level) or in a small amount of tissue during surgery for other reasons (such as benign prostatic hyperplasia). The PSA level is lower than 10 and the Gleason score is 6 or lower; or
is found in one-half or less of one lobe of the prostate. The PSA level is lower than 10 and the Gleason score is 6 or lower; or
cannot be felt during a digital rectal exam and is not visible by imaging. Cancer is found in one-half or less of one lobe of the prostate. The PSA level and the Gleason score are not known.
In stage II, cancer is more advanced than in stage I, but has not spread outside the prostate. Stage II is divided into stage IIA and stage IIB.
In stage IIA, cancer:
is found by needle biopsy (such as for a high PSA level) or in a small amount of tissue during surgery for other reasons (such as benign prostatic hyperplasia). The PSA level is lower than 20 and the Gleason score is 7; or
is found by needle biopsy (such as for a high PSA level) or in a small amount of tissue during surgery for other reasons (such as benign prostatic hyperplasia). The PSA level is at least 10 but lower than 20 and the Gleason score is 6 or lower; or
is found in one-half or less of one lobe of the prostate. The PSA level is at least 10 but lower than 20 and the Gleason score is 6 or lower; or
is found in one-half or less of one lobe of the prostate. The PSA level is lower than 20 and the Gleason score is 7; or
is found in more than one-half of one lobe of the prostate. The PSA level is lower than 20 and the Gleason score is 7 or lower; or
is found in more than one-half of one lobe of the prostate. The PSA level and the Gleason score are not known.
In stage IIB, cancer:
is found in both lobes of the prostate. The PSA can be any level and the Gleason score can range from 2 to 10; or
cannot be felt during a digital rectal exam and is not visible by imaging, and the tumor has not spread outside the prostate. The PSA level is 20 or higher and the Gleason score can range from 2 to 10; or
cannot be felt during a digital rectal exam and is not visible by imaging, and the tumor has not spread outside the prostate. The PSA can be any level and the Gleason score is 8 or higher.
In stage III, cancer has spread beyond the outer layer of the prostate on one or both sides and may have spread to the seminal vesicles. The PSA can be any level and the Gleason score can range from 2 to 10. Stage IV
In stage IV, the PSA can be any level and the Gleason score can range from 2 to 10. Also, cancer:
has spread beyond the seminal vesicles to nearby tissue or organs, such as the rectum, bladder, or pelvic wall; or
may have spread to the seminal vesicles or to nearby tissue or organs, such as the rectum, bladder, or pelvic wall. Cancer has spread to nearby lymph nodes; or
has spread to distant parts of the body, which may include lymph nodes or bones. Prostate cancer often spreads to the bones.
Recurrent Prostate Cancer
Recurrent prostate cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the prostate or in other parts of the body.
Treatment Option Overview
There are different types of treatment for patients with prostate cancer.
Five types of standard treatment are used:
New types of treatment are being tested in clinical trials.
Biologic therapy
High-intensity focused ultrasound
Proton beam radiation therapy
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Different types of treatment are available for patients with prostate cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Watchful waiting is closely monitoring a patient's condition without giving any treatment until symptoms appear or change. This is usually used in older men with other medical problems and early- stage disease.
Patients in good health are usually offered surgery as treatment for prostate cancer. The following types of surgery are used:
Pelvic lymphadenectomy: A surgical procedure to remove the lymph nodes in the pelvis. A pathologist views the tissue under a microscope to look for cancer cells. If the lymph nodes contain cancer, the doctor will not remove the prostate and may recommend other treatment.
Radical prostatectomy: A surgical procedure to remove the prostate, surrounding tissue, and seminal vesicles. There are 2 types of radical prostatectomy:
Retropubic prostatectomy: A surgical procedure to remove the prostate through an incision (cut) in the abdominal wall. Removal of nearby lymph nodes may be done at the same time.
Perineal prostatectomy: A surgical procedure to remove the prostate through an incision (cut) made in the perineum (area between the scrotum and anus). Nearby lymph nodes may also be removed through a separate incision in the abdomen.
Transurethral resection of the prostate (TURP): A surgical procedure to remove tissue from the prostate using a resectoscope (a thin, lighted tube with a cutting tool) inserted through the urethra. This procedure is sometimes done to relieve symptoms caused by a tumor before other cancer treatment is given. Transurethral resection of the prostate may also be done in men who cannot have a radical prostatectomy because of age or illness.
Impotence and leakage of urine from the bladder or stool from the rectum may occur in men treated with surgery. In some cases, doctors can use a technique known as nerve-sparing surgery. This type of surgery may save the nerves that control erection. However, men with large tumors or tumors that are very close to the nerves may not be able to have this surgery.
The penis may be 1 to 2 centimeters shorter after a radical prostatectomy. The exact reason for this is not known.
Inguinal hernia is bulging of fat or part of the small intestine through weak muscles into the groin. Inguinal hernia may occur more often in men treated with radical prostatectomy than in men who have some other types of prostate surgery, radiation therapy, or prostate biopsy alone. It is most likely to occur within the first 2 years after radical prostatectomy.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.
There is an increased risk of bladder cancer and/or rectal cancer in men treated with radiation therapy.
Impotence and urinary problems may occur in men treated with radiation therapy.
Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. In prostate cancer, male sex hormones can cause prostate cancer to grow. Drugs, surgery, or other hormones are used to reduce the production of male hormones or block them from working.
Hormone therapy used in the treatment of prostate cancer may include the following:
Luteinizing hormone-releasing hormone agonists can prevent the testicles from producing testosterone. Examples are leuprolide, goserelin, and buserelin.
Antiandrogens can block the action of androgens (hormones that promote male sex characteristics). Two examples are flutamide and nilutamide.
Drugs that can prevent the adrenal glands from making androgens include ketoconazole and aminoglutethimide.
Orchiectomy is a surgical procedure to remove one or both testicles, the main source of male hormones, to decrease hormone production.
Estrogens (hormones that promote female sex characteristics) can prevent the testicles from producing testosterone. However, estrogens are seldom used today in the treatment of prostate cancer because of the risk of serious side effects.
Hot flashes, impaired sexual function, loss of desire for sex, and weakened bones may occur in men treated with hormone therapy. Other side effects include diarrhea, nausea, and pruritus (itching).
See Drugs Approved for Prostate Cancer for more information.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI Web site.
Cryosurgery is a treatment that uses an instrument to freeze and destroy prostate cancer cells. This type of treatment is also called cryotherapy.
Impotence and leakage of urine from the bladder or stool from the rectum may occur in men treated with cryosurgery.
Biologic therapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.
High-intensity focused ultrasound is a treatment that uses ultrasound (high-energy sound waves) to destroy cancer cells. To treat prostate cancer, an endorectal probe is used to make the sound waves.
Proton beam radiation therapy is a type of high-energy, external radiation therapy that targets tumors with streams of protons (small, positively charged particles). This type of radiation therapy is being studied in the treatment of prostate cancer.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests. This is sometimes called re-staging.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
Treatment Options by Stage
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Stage I Prostate Cancer
Treatment of stage I prostate cancer may include the following:
Watchful waiting.
Radical prostatectomy, usually with pelvic lymphadenectomy, with or without radiation therapy after surgery. It may be possible to remove the prostate without damaging nerves that are necessary for an erection.
External-beam radiation therapy.
Implant radiation therapy.
A clinical trial of high-intensity focused ultrasound.
A clinical trial testing new types of treatment.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I prostate cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage II Prostate Cancer
Treatment of stage II prostate cancer may include the following:
Radical prostatectomy, with or without pelvic lymphadenectomy. Radiation therapy may be given after surgery. It may be possible to remove the prostate without damaging nerves that are necessary for an erection.
External-beam radiation therapy with or without hormone therapy.
A clinical trial of radiation therapy with or without hormone therapy.
A clinical trial of ultrasound -guided cryosurgery.
A clinical trial of proton beam radiation therapy.
Clinical trials testing new types of treatment, such as hormone therapy followed by radical prostatectomy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage II prostate cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage III Prostate Cancer
Treatment of stage III prostate cancer may include the following:
Hormone therapy.
Radical prostatectomy, with or without pelvic lymphadenectomy. Radiation therapy may be given after surgery.
Radiation therapy, hormone therapy, or transurethral resection of the prostate as palliative therapy to relieve symptoms caused by the cancer.
A clinical trial of radiation therapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage III prostate cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage IV Prostate Cancer
Treatment of stage IV prostate cancer may include the following:
Radiation therapy or transurethral resection of the prostate as palliative therapy to relieve symptoms caused by the cancer.
A clinical trial of radical prostatectomy with orchiectomy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage IV prostate cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Treatment Options for Recurrent Prostate Cancer
Treatment of recurrent prostate cancer may include the following:
Radiation therapy.
Prostatectomy for patients initially treated with radiation therapy.
Chemotherapy.
Pain medication, external radiation therapy, internal radiation therapy with radioisotopes such as strontium-89, or other treatments as palliative therapy to lessen bone pain.
A clinical trial of new anticancer drugs or biological therapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent prostate cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
To Learn More About Prostate Cancer
For more information from the National Cancer Institute about prostate cancer, see the following:
Prostate Cancer Home Page
What You Need to Know About™ Prostate Cancer
Prostate-Specific Antigen (PSA) Test
Treatment Choices for Men with Early-Stage Prostate Cancer
Drugs Approved for Prostate Cancer
Cryosurgery in Cancer Treatment: Questions and Answers
For general cancer information and other resources from the National Cancer Institute, see the following:
What You Need to Know About™ Cancer
Understanding Cancer Series: Cancer
Cancer Staging
Chemotherapy and You: Support for People With Cancer
Radiation Therapy and You: Support for People With Cancer
Coping with Cancer: Supportive and Palliative Care
Cancer Library
Information For Survivors/Caregivers/Advocates
For more information about Prostate Cancer, please visit the National Cancer Institute.
Colon and Rectal Cancer
Hematology & Blood Disorders
Five Atlanta Area Locations
Providing the highest quality cancer treatment services close to home.
1800 Howell Mill Rd.
1240 Eagles Landing Pkwy
755 Mount Vernon Hwy.
Coming 2022!
Charles A. Henderson, MD, Emeritus
W. Perry Ballard, III, MD, Emeritus
R. Martin York, MD, Emeritus
Robert S. Allen, MD, Emeritus
© 2022, Piedmont Cancer Institute, Atlanta, Fayetteville, Newnan, Sandy Springs, Stockbridge.
Medical Website Design & Hosting by Medical Management Associates, Inc.


Janssen Pharmaceuticals, the arm of Johnson & Johnson behind the anti-seizure drug Topamax, is the target of over 100 lawsuits in the Philadelphia Court of Common Pleas. The pharmaceutical company is currently defending itself in a Topamax birth defects lawsuit involving a family from Wisconsin. The plaintiffs in the case have a child whose birth defects they allege are the result of exposure to Topamax in the womb.
According to Law360, the Wisconsin family filed their Topamax lawsuit against Janssen Pharmaceuticals claiming that the drug manufacturer neglected to adequately advise health care providers and patients about the risks associated with Topamax use during pregnancy. The most commonly reported Topamax birth defect in children exposed to the drug in the womb include oral defects, cleft lip and/or cleft palate.
The St. Louis class action attorneys at Carey Danis & Lowe represent families whose children have suffered from Topamax birth defects. We are a national law firm experienced in class action litigation, and we specialize in pharmaceutical product liability lawsuits. If your child was born with congenital birth defects as a result of Topamax exposure, we encourage you to discuss your legal options and compensation eligibility with one of our Topamax lawyers today. Our initial case evaluations are free.
Carey Danis & Lowe is available now to discuss your Topamax story. Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing one of our personal injury claim forms.


text:
<!-- drawable/view_grid.xml -->
<vector xmlns:android="http://schemas.android.com/apk/res/android"
    android:height="24dp"
    android:width="24dp"
    android:viewportWidth="24"
    android:viewportHeight="24">
    <path android:fillColor="@android:color/black" android:pathData="M3,11H11V3H3M3,21H11V13H3M13,21H21V13H13M13,3V11H21V3" />
</vector>

redpajama_set_name: RedPajamaGithub


Cannabis Companies | Starting with "K"
KushMart (South Everett) is the newest recreational cannabis dispensary in South Everett with the best prices in the region. We have a great selection from some of the best Washington processors and producers.
Kono Naturals is a collection of organic, sustainable hemp-based cannabidiol (CBD) products carefully designed to offer a safe and natural alternative to managing pain, mental health and promoting general wellness.
Kip Morrison and Associates strives to deliver a top-notch level experience and expertise to drive measurable results for each of our clients. Headquartered in Beverly Hills, KMA is one of the few PR agencies with over 30 years of successful reach in the industry.
KenG Fence is a professional fence and gate repair or replacement contractor serving both Denver and Boulder CO.
Kind Traditions Consulting provides management/financial consulting services to all types of cannabis related companies, including profitability analysis, cost analysis, financial reporting, ERP systems, and more.
Page 1 of 5 starting with "K"


This entire debacle regarding Wilson is dishonest to the core and is merely being done to distract the American public from the health care debate. Wake up and stop being so partisan – start calling a spade a spade, and admit to the hypocrisy: That's all I ask!
I have Journey's song playing in my head after Joe Wilson's outburst Wednesday night. Joe Wilson exclaimed "You Lie!" regarding President Obama's assertion that illegal aliens would not be covered in any health care legislation, however, under all but one version of the health care bills, illegal aliens would in fact be allowed to partake in the system (no proof of documentation required).
This is something that was discovered several weeks ago by those citizens who actually took the time to read through the bills as they became available to the public. There were other provisions in the draft legislation that also raised various red flags.
The AP, of all publications, ran a mostly objective fact check on the President's speech and found that he most certainly lied regarding that issue as well as various others.
People could argue day and night over the issue of right and wrong and the appropriateness of Joe Wilson's remarks. There will always be those who agree with the timing of his remark and those who do not. It's just that simple. Don't cloud the issue of health care by demonizing a politician and distracting the American public when plenty of politicians have done the same thing in other forums.
I find it incredibly hypocritical to hear President Obama call Sarah Palin a liar, because she made complete sense in her recent Wall Street Journal op-ed, continue to blame Bush for everything, and state that Republicans do not have solutions, but feign outrage when somebody shouts out at a specific part of legislation that has been blatantly falsified, and all hell breaks loose.
I have to wonder in wild amazement how Democrats can be so blind to their history of doing the same things that they get so riled up about. I realize that there are hypocrites on both sides of the aisle, but give it a rest. How many times did specific liberal politicians give an interview during Bush's term in office stating that he was a liar? How many times did Democrats like Harry Reid make disparaging remarks about the support of our troops by stating that the War was lost? What about Nancy Pelosi's recent CIA accusation, where she called them liars? I could go on, but I'll leave it there. The selective outrage of the liberal wing of the Democrat party is astounding, if not so pathetic.


text:
Why Einstein's Theory Of Gravity Is Under Scrutiny Following A New Study
Hulton Archive/Getty Images
By Dylan Hofer/Updated: Dec. 7, 2022 11:28 am EST
Albert Einstein is often lumped together in the group of the world's most renowned geniuses, with the likes of Nikola Tesla, Isaac Newton, and Leonardo Da Vinci, just to name a few. Einstein's most famous contribution to science was his theory of general relativity, giving us the equation E = mc2. His ideas were revolutionary for the time, and they changed the world and physics as we knew it, allowing us to understand the universe in a deeper manner. But after all these years, scientists are still holding his ideas to scrutiny, and it turns out there may be some error in his discoveries (via LiveScience).
But in order to understand how Einstein's theory may have discrepancies, it's important to look at the history of how general relativity became the leading theory in the physics community. Before Einstein, many physicists subscribed to the ideas of Isaac Newton, who proposed universal gravitation, the idea that every particle in the universe attracted one another via gravity, and that this occurred everywhere in the cosmos, according to Openstax.
Before Einstein
There were some errors in Isaac Newton's theory, however, and Albert Einstein sought to resolve them. For the most part, Newton's theories on gravity held up to scientific scrutiny, and for a long time, the vast majority of physicists supported his idea. However, something that was hard to explain using these laws was the ability for light to travel, according to Space.com. Thus, the idea of the ether came into being.
This ether concept was believed to be a type of energy source that acted as a medium across the entire universe, coming into contact with every single particle without being able to be measured because it was constant and never changing, according to Britannica. For the most part, the ether was universally accepted, but one experiment looked to prove the existence of the ether once in for all, the Michelson-Morley experiment. The researchers were looking to track Earth's movement through the ether and compare the light levels with light levels perpendicular to the trajectory path and see if there was a difference, which would prove the existence of the ether. However, they found no change, and physics as they knew it was turned on its head (via Britannica).
Nikolay 007/Shutterstock
As physicists entered a frenzy to deal with the catastrophic blow the scientific world had been dealt, Albert Einstein came to fix the issue with his idea of special relativity. Einstein proposed that electromagnetic waves, which included light, were universal constants. Objects could never surpass the speed of light; rather, the mass only becomes increasingly difficult with more and more density (via Space.com).
Einstein explained this idea with the example of a hypothetical train. Imagine that there are two people, one on the outside of the train at the station and the other on board, both observing two trees at opposite ends from one another. The train is moving at 99.5% light speed and the person at the station is moving relatively normally to the speed of Earth's rotation around the sun. Then, a storm occurs, and lightning strikes the two trees at the same time. Einstein pointed out that the observer moving near the speed of light would see the tree ahead of them being struck first because they are moving faster towards that tree than the other, thus proving that time is relative, not the speed of light, according to Space.com.
Kryssia Campos/Getty Images
Einstein's theory of special relativity was published in 1905, but it took another 10 years for him to devise his theory of general relativity. Einstein came to the conclusion that objects in the spacetime continuum actually "bend" space itself, thus creating the effect of gravity. To better picture this effect, imagine holding a blanket perfectly flat at all four corners and having someone put a bowling ball or some other spherical object on the blanket. It would fold, wouldn't it? This is exactly how Einstein thought gravity worked, and it turns out he was correct.
In order to prove his hypothesis, he needed to predict this curving of spacetime in real-time. A group of researchers traveled to different points in the Southern hemisphere to observe a solar eclipse, but more specifically, stars during this event. Normally, Einstein's theory would've been hard to test, since the sun blocks out other light coming from different celestial bodies. With the sun being darkened by the eclipse, however, researchers would be able to photograph and compare with Einstein's predictions of deflection. When the pictures were taken, Einstein's equations held true, and thus much of the scientific community accepted his idea of general relativity, according to Britannica.
Weird world of quantum mechanics
Pixelparticle/Getty Images
Albert Einstein may not have been completely right about everything, however, and some new studies show that there may be some slight problems with the theory of general relativity. For one, there is the quantum problem. Einstein proposed that empty space, known as the vacuum, has an energy that cannot be detected because it doesn't change. This energy gravitates, but in a repulsive manner — pushing things away, according to LiveScience. Therefore, it actually pushes things away from one another, which helps explain how the universe is actually expanding.
But the problem lies in the mathematical equations of general relativity itself. The theory proposes that the energy needed for the rate of expansion of the universe would be much larger than what we actually see, which may mean that there is something else contributing to this acceleration. The main problem scientists observing this phenomenon come into is something dubbed the Hubble tension. This occurs when two different measurements are used for the Hubble constant: one being the light remaining after the Big Bang and the other being the rate of universal expansion. These measurements are used to predict the rate of acceleration of universal expansion (via Live Science).
The edge of what we know
Researchers conducted a test to try to resolve the Hubble tension, and they did this by examining the expansion of the universe, the curvature of matter, and the curvature of light all at the same time. They then measured the variables by examining the radiation left over from the Big Bang, supernovas, and the way galaxies were structured. They compared their results for what the variables should be compared to Einstein's own model and found that there might be some statistical error between the different models, according to LiveScience.
However, this is most likely the result of a lack of knowledge, says Advanced Science News. One of the scientists who worked on this study, Levon Pogosian, claimed that he believes there might've been other particles, or interactions with dark matter, during the early days of the universe that might've interfered with the expansion of the universe in ways we can't fully comprehend today. If that is the result, there will need to be some drastic changes to the way physicians look at the universe. And who knows, maybe this is a stepping stone to our own modern-day version of a groundbreaking discovery that shatters everything we think we know. Perhaps that's the beauty of it all, and the purpose of science itself.


Breakwater Hotel at the beach is a boutique 3.5-Star hotel just steps from the beach and blocks from Historic Downtown shopping and restaurants. We offer our guests an unbeatable value and experience on Amelia Island with an unparalleled resort package in a relaxing atmosphere. Throughout 2018, Breakwater Hotel Amelia Island will undergo a multi-million dollar transformation to create a 4-Star quality paradise our guests can return to year after year. Breakwater Hotel Amelia Island guest rooms will be entirely rebuilt to four-star quality standards. The exterior of the hotel will be completely updated. Our swimming pool area will be redesigned as a fabulous area with lush tropical landscaping, a large pool (double the size of the current pool) and a lazy river.


Being aware of ways to discuss effectively in general public has become the greatest obstructions to the individual. It is no wonder that public speaking may be the greatest dread of humanity, and that astonishingly overcomes the dread of death. But what's the explanation for this? Exactly what is concerned within a person's intellect after they see themselves about to discuss in public? Community talking is usually a present or it truly is achievable for any person to realize.
By far the most introverted or timid ones need to certainly obtain by themselves the worst beings on the deal with in the earth since (they feel) they'll under no circumstances manage to speak in public. But even people that are talkers also conclude up suffering some sort of fear every time they need to have to speak with many individuals within the exact same time.
Failure to talk in general public can have damaging repercussions to get a individual, no matter if from the particular industry or during the professional area. Noises or very poor expression when speaking can interfere with friendships or stop a sale. In each professional and private fields, achievements may be a shorter route if there is the flexibility to talk properly in community. And in people times you must reveal stability and self-control.
So here are 6 ideas to replicate and apply in pursuit on the ability to speak nicely in public after which you can most likely increase the likelihood of success by way of conversation.
1st you might have to detect the signs which might be connected to this fear and that can occur prior to deciding to even start to discuss in community.
In this article the indications of your body may be a lot more evident and position to an psychological disturbance. Should the person in the course of the function perceives these indicators he need to endeavor to control them making sure that they are doing not increase. But before the event you could undertake a strategy of marketing quiet by means of tunes that take it easy and try to distinct absent the excessive ideas about what you're gonna say and for whom.
Your audience will position more trust in you the greater you reveal mastery above what you're speaking about. This creates a romance of respect and attention. Your self-confidence in addressing the subject will even become a potent aspect in your overall performance. On the other hand, referring to a topic devoid of dominating it only boosts the insecurity that demonstrates in the thoughts of those that must speak by making a ongoing feeling of worry in earning blunders.
So investigation and research this well as well as try and anticipate attainable thoughts. Research them, as well.
For just a assembly, team dynamics or lecture the start ordinarily is usually quite possibly the most complex. As a result, the method would be to operate to beat this barrier and then launch soon.
Right after you have been talking for approximately 10 minutes, you have a tendency to receive utilized towards the problem towards the place of loosing far more from the rest of your party. So get ready your brain to be familiar with that following a few minutes almost everything will increase.
Means that could lead to enhance the final results of your respective presentation: Microphone, slides, dynamics, handouts and so one. Human memory incorporates a mother nature of forgetting what has actually been uncovered in just a number of times. However it is probable to better safe this studying by means of using multimedia methods. But don't let these options go ahead and take greater interest of your presentation. Ensure they only potentiate the information.
Illustrations or photos talk a lot more than lots of, numerous, words.
The idea is always to enrich (but stay clear of abusing) the usage of methods with photos (films, pictures, internet websites, tales, real cases, graphics, and so forth.) that illustrate the topic. This will make the subject additional calm and easy the two to elucidate and to recognize.
Deliver the viewers for you by sharing your awareness with several people today all through your speech. This may crank out increased general public participation in addition to make men and women more aware. For that reason, endeavor to foster interactivity, inquiring issues or accomplishing dynamics as being a method to stimulate participation. Eventually, figuring out the best way to communicate very well in general public is among the techniques which the market place calls for. Especially now, when communicating with substantial teams of consumers and specialist partners – equally bodily and by digital signifies – is ever more popular many thanks to technological and conversation progression.
And now, that you choose to previously know of our suggestions and procedures, what about traveling to http://quemviveaprende.blogspot.com/2018/01/learn-6-techniques-to-speak-well-in.html ?


The goal of this campaign was to promote one of the Pilot brand's latest models, the Frixion. The main feature of this model was that you can both write and erase. Based on this premiere, the main task was to offer an unprecedented reading of the history of evolution in which the pen —a metaphor for divine intervention— provides a solution each time a problem arises. It allow the species to evolve correctly through each of their stages. "Create, remove, evolve;" states the spot. Created by the agency Grey, the campaign combined cell animation and stop motion techniques. Aired in Spain and Portugal, it has 20", 30", 60" and 90" versions.
Featured in // Boardsmag, Best of 2010 @ Fubiz, Stash issue 74 and The Reel magazine.


text:
Why 'Grey's Anatomy' Fans Love This 'Flawed' Character So Much
Ashley Swallow
Few shows can compete with the fame and fans of Grey's Anatomy. Since season one Grey's Anatomy has been known for its dramatic storylines and, of course, the iconic and compelling characters. George O'Malley and Christina Yang were two fan-favorites who have since departed the show, but many of the most-loved characters are the ones that have been there since day one or, in this case, since episode one.
Take a closer look at the series and why fans of Grey's Anatomy love this "flawed" character so much.
The beloved cast and characters of ABC's 'Grey's Anatomy'
KEVIN MCKIDD, KIM RAVER, JAMES PICKENS JR. | Ali Goldstein/ABC via Getty Images
RELATED: 'Grey's Anatomy': Why Chyler Leigh Couldn't Film Her Scenes with Ellen Pompeo and Eric Dane in Person
Over the years, Grey's Anatomy has had some outstanding actors and actresses on the cast of the medical-based drama. Of course, fans of the series probably fondly remember Katherine Heigl as Izzie Stevens. Patrick Dempsey was another highly-favored actor who was cast as a main character when Grey's Anatomy first premiered.
Nowadays, the cast looks a little different from season one, but there are still many original and familiar faces. Chandra Wilson's character Miranda Bailey has been a staple of the show since season one. Ellen Pompeo, the talented actress who plays Meredith Grey, has in so many ways become the face of the popular series.
There have also been some new and welcomed additions throughout the seasons. Jackson Avery is just one of them. Jesse Williams is the handsome and skilled actor who plays his role. It is hard to pick a favorite, but it seems like fans and viewers of the series may already have.
All the times Dr. Webber wowed us with his wisdom! #Greys300 pic.twitter.com/KCx9CNBGNx
— Greys Anatomy (@GreysABC) November 4, 2017
RELATED:'Grey's Anatomy': People Love Richard So Much They Forget All the Terrible Things He's Done
Fans and viewers of the series often go to Reddit to discuss all things Grey's Anatomy. This Reddit thread was no exception. Loyal fans of the television show have just about seen it all, and through the good and the bad there is one character that audiences typically find themselves rooting for. That "flawed" character that so many viewers love is indeed Richard Webber.
The Reddit thread highlights an endless amount of reasons why people adore his character. From his paternal vibes to Richard Webber's signature pep talks, the list and discussion went on and on. One user seemed to say it best and wrote, "I love Richard. A very flawed character but one of the most interesting for sure. Well written and well acted – I wouldn't say James Pickens jr is necessarily one of the best actors on paper but he really brings Webber to life." Many of the comments echoed similar sentiments.
Some of Richard Webber's most memorable moments on 'Grey's Anatomy'
Dr. Webber pep talks? Yes, please! #GreysAnatomy https://t.co/YvLGuvscyA
— Greys Anatomy (@GreysABC) January 30, 2016
RELATED: 'Grey's Anatomy': Is Richard Webber Leaving? Fans Are Worried About the Character's Future
In the Reddit discussion many fans used the thread as an opportunity to reflect on some of their favorite Richard Webber moments. One user reminiscing wrote, "Richard has the most funniest moments in a show like Grey's, especially that twitter episode where you wanted to see Bailey's "teets". Lol". Another person brought up the dance moves he showed off just the other week to quietly and safely celebrate the good news of Meredith Grey's improving health.
Of course, many of fans' favorite moments and scenes were from when he was "the chief". Ironically enough, even when he stepped down from the role, he still went as "the chief". Many fans think this is a sign of the character's insurmountable respect and leadership skills. Nevertheless, even though he isn't perfect, Richard Webber is definitely one of the fans' favorites.


Ferrous Moon • Revelation bug?
it's gotten to the point in the game where ARC and Arunmor go head to head, and the former have sent me an email containing revelation.
Except it doesn't. it doesn't appear in the data bank of either my main or auxilliary gateways, so I broke into ARC's servers. all of them, but it wasn't found there, only a mysterious reference to revelation 0.7 being deleted. So is it a bug, or some kind of puzzle that's gone completely over my head?
Post subject: Re: Revelation bug?
thanks for the help. Now to kick ARC in the balls for their user unfriendliness.


Rudolf Diesel invented the diesel engine in the late 1800's. When he exhibited his engine at the Paris World's fair, it was with peanut oil as the fuel. He envisioned his engine as being able to run on multiple fuels, including vegetable oil.
We can always hope, but the facts are that if we used all our farmland to grow vegetable oils, we would only be able to replace a small percentage of petroleum diesel fuel.
In the beginning, the diesel engine would run on just about anything with enough BTUs. Over the years, the diesel engine was fine-tuned to run more efficiently on petroleum. Also, the fuel has been changed to improve reliability and reduce emission. All of this "improving" prevents us from dumping vegetable oil directly in the fuel tank of modern diesel engines.
We can blend our vegetable oil with solvents like gasoline and turpentine to give it properties closer to diesel fuel.
We can modify our diesel engine so that it can operate reliably longer on unmodified vegetable oil.
Making biodiesel requires purchasing and working with dangerous chemicals. Making biodiesel also generates a hazardous waste stream that causes all sorts of problems. There has been a lot of research on making, and using biodiesel, and we know biodiesel can be used indefinitely and still maintain a high degree of reliability.
Blending modifies the fuel without most of the problems of making biodiesel, and you don't need to modify your engine. It is highly experimental, and while some have run over 50K miles with no problems, others have had to replace the entire fuel system after only a few thousand miles. Blending is best done on an older (disposable) vehicle.
Converting your vehicle to run reliably on vegetable oil can be a little bit expensive. Once converted, the cost is less than 50 cents a gallon. That is if we use WVO (used or Waste Vegetable Oil) that we collect from kitchen fryers. New, unused Vegetable oil can cost significantly more.


text:
package de.v13dev.designpatterns.facade;

public class Facade {

    private final Subsystem1 subsystem1;
    private final Subsystem2 subsystem2;
    private final Subsystem3 subsystem3;

    public Facade(Subsystem1 subsystem1, Subsystem2 subsystem2, Subsystem3 subsystem3) {
        this.subsystem1 = subsystem1;
        this.subsystem2 = subsystem2;
        this.subsystem3 = subsystem3;
    }

    public int getSumOfSubsystems() {
        return subsystem1.getNumber() + subsystem2.getNumber() + subsystem3.getNumber();
    }
}


A limited-budget product launch involving the education of consumers on the driving concept behind the product: a "healthy" gourmet coffee. Applied Food Science's patented roasting process creates a rich, specialty-end coffee with more antioxidants than most green tea. The key challenge would be to communicate the healthful benefits of the product while asserting its rich, delicious taste (comparable to that of other specialty gourmet blends).
The development of a brand name, logo, tag line, and package that instantly conveyed all the key elements of the new coffee in a synergistic manner. The brand name: Caffe Sanora (derived from Sano, the Italian word for health). The tagline: "A Great Cup of Good Health." The logo and package: Rich looking, custom-illustrated labels and attitude-capturing logo work together to create a package with a high-end, gourmet feel.
Applied Food Sciences launched the product in Denver, Colorado and noticed an immediate positive response in the marketplace. The product was launched in several gourmet shops and supermarkets and has been featured on CNN, NBC, and the WB. The first Caffe Sanora coffeehouse opened in Denver in October of 2005.


text:
Reactions to this week's Friday OT...
...have made me laugh no end.
At time of this post (10:30am Saturday) I've received 24 (yes, twenty-four) mails on yesterday's Friday OT, with precisely 12 congratulating on the choice and precisely 12 hating on the choice, which if memory serves is the largest amount of mailbag received on any post about any subject, let alone a Friday OT. I thank you all for your mails and opinions and again make my position of pro-Dancing Queen clearly stated, but who'd have thought that a 70's band from Sweden would be the root cause of such a polemic split in society?
Congratulations Peru, now world's number one!
In potential cocaine production. Here's the link to the DEA testimony last week, here's the chart:
As for a few observations....
It's worth noting that Bolivia's "potential" cocaine production number is surely way higher than the actual, because Bolivia uses a lot of its coca leaves for its traditional purposes (chewing, coca tea, ceremonies etc). That's also true to some extent in Peru. However Colombia has no tradition of coca uses outside of cocaine manufacturing, so that 270 metric tonnes number is probably all dedicated to cocaine production.
Plan Colombia has cut into cocaine production in Colombia, no doubts on that. However it's largely the crackdown against the FARC-EP and the right wing paramilitaries that's seen the progress, more than the well-documented crop spraying campaigns.
Peru has been ignored on the world scale, with Colombia the US target of choice and then Bolivia because of its "anti-US" stance (or at least, that's the line you guys are fed up there and the truth is far more nuanced). But Peru, with its "US-Friendly" Alan García government, has been ignored. So production of cocaine has grown.
Funny how Peru suddenly jumps up the agenda when a left wing President takes power, innit?
DYODD, dude
Labels: bolivia, cocaine, colombia, DEA, peru
The Friday OT: Abba; Dancing Queen
Best pop song ever.
After catching up with the market action and week's news today...
...it really does look like a great time to do some cheap buying. The ones I'd go for are the juniors that do decent volume, be they explorers or producers, and got beaten down yesterday on the samo samo world-gonna-end stuff and haven't seen much of a bounceback today. Preference would be for gold-exposed names, but the way things are right now I'd happily go with silver or base metals plays too...as long as they run plenty daily volume and you can get in and out with relative ease.
For those of you with more patience the less liquid issues have some stonking looking bargains amongst them too, but more patience with entry and exit is always needed so they're not really suited for the quickflip scenario.
I'll tell a true truth about site visits
Some are easier than others, conditions-wise at least. This photo taken yesterday morning.
The weather may have been cruddy but the project was well worth its visit. More photos, a full write-up and numbercrunching in IKN129 this weekend, subscribers.
Gold (GLD) versus silver (SLV) versus gold miners (GDX) versus junior miners (GDXJ) the last five days:
All bad, but metals beat miners in the orderly fashion you'd expect. However the pre-market shows a rebound for today. Something for the weekend, sir?
...it's very useful to be out of interwebnetpipes range for a couple of days. For example, I didn't have to worry about this:
And Cu is doing the nice thing and bouncing overnight, too. Meanwhile, this links to a special report from Reuters today entitled, "CHINA'S COMMODITY DEMAND RESILIENT TO EXTERNAL HEADWINDS"
Breaking: Car bomb at a Peru police station
Reports so far are patchy, but say that a car bomb probably based on dynamite exploded outside the main police station in the city of Juliaca, Peru region, just after 8pm EST (7pm local time) tonight and that there are dead police on the scene.
update: latest is three dead including one police officer and buildings and windows detroyed all round the police station
update 2: Now it's a truck filled with fireworks that went up, leaving seven dead including four police officers plus a whole heap of injured. Report and video of the scene here
A quick update on Jaguar (JAG) (JAG.to) before heading into the wild woods
xAnyway, have a pleasant day.
Jaguar Mining (JAG) (JAG.to): Tristeza não tem fim
The non-stop train-wreck of a gold mining company known as Jaguar Mining (JAG.to) (JAG) reported its 3q11 production numbers this evening and as usual the company had a disappointment in store. Not that you'd notice it at first, of course, because all the lyrical waxing and such in the first paragraphs about record this, record that and record the other. Nah, to get to the real story you had to read the whole thing, because the serial bullshitters running JAG always leave the worst bit til last.
By way of context, back in the 1q11 MD&A, JAG set out its production estimates for the years ahead like this:
2011-2015 Estimated Production and Cash Operating Costs
The Company's 2011-2015 gold production estimates are as follows:
Year Gold Production (ounces)
2011 195,000 – 205,000
In other words, JAG said to the world that it would produce between 195,000 and 205,000 ounces of gold this year. In that same document it predicted those ounces would be produced at a cash cost of between $660 and $700 per ounce
So to the 2q11 MD&A, dated August 10th this year (just two and a bit months ago, you'll note). In that official company we were told this:
"Although production for the quarter ended June 30, 2011 was impacted by mill issues at Caeté, Jaguar's management believes its year-to-date operating results, mine improvements and new development are consistent with achieving 2011 production at the lower end of the guidance range."
OK, fair enough. Perhaps at the 195,000 oz of production, but JAG said it would make its guidance. So to the production report, out tonight. Here's what the company says now:
"Based on actual production during the first three quarters of the year, the current rate of production at the Company's mining operations and the mill issues at Paciência described above, Jaguar's management now expects 2011 full year production to be in the range of 155,000 to 163,000 ounces of gold at an average cash operating cost in the range of $835 to $845 per ounce."
Owl please!
In other words, as late as August 2011 JAG assured the market it would be able to run its mines at 55,000 oz or 60,000 oz Au per quarter to reach its guidance after two quarters of 40k production as seen here....
1q11 prod 41,449
4q11est prod 40,000
...but now it says that the mines will run at 40k/qtr.....hmm, slight difference, no? And while we're at it, that "$660/oz to $700/oz" cash cost estimate has drifted higher, to $835 and $840/oz.
It's not the fact that JAG is bullshitting the market this year that makes reason for a post such as today, either. It's the fact that JAG bullshits the market every freakin' year and here's a great example of the never-ending guff'n'nonsense we get from JAG, a cutting from its October 2007 presentation to analysts
On target! ON TARGET! Apparently we should be looking at a company with 400k annum production in 2011, but it can't even reach 200k! This woeful company will still be able to pull the wool over the eyes of the naive end of the investment universe in the quarters and years to come. Just make sure you're not one of the suckers it fools this time. DYODD.
Jack's back.
Posting will be light until Friday, as your humble scribe goes off and pretends to do some work in a more rural setting. So for your further education, edification and enlightenment, here's a slab of Jack to muse upon until then.
I can just see the shabby literary man carrying a "bulging briefcase" rushing from one campus to another, one lecture club to another, nodding confirmation with his hosts that he is right, hurrying to the next town ... a whole gray career of proving himself to others, to as many as can hear him, that he was right ... till finally people say: "Here comes the self-prover again, O dear ... bring out the papers and the canapes." This my friend is what I will become if I accept all lecture offers, TV appearances, radio interviews and start arranging with reviewers and critics who want information and my books through me, a great long lifetime in a briefcase proving my work and my work itself stopped dead at the level where I took to proving myself. So, I say, life is too sweet to waste on self propaganda, I quit self promotion, I enter my page.
Labels: jack kerouac
The "Junior Mining News Release Guffaw of the Day" award goes to...
...Amerix Precious Metals (APM.v).
There's a line in Monty Python's Life of Brian where Judith (Brian's girlfriend) runs into the HQ of the PFJ* and tells the committee that Brian has just been arrested. Cleese's character in the scene then says,
"Right! This calls for IMMEDIATE discussion!"
So your humble scribe thanks Amerix (APM.v) for the memory today when on opening the company's NR this was read:
"Amerix is planning an aggressive campaign of follow up geochemical sampling of all the potential gold targets on the Limão property over the upcoming months."
Well, I LOL'd. Ain't nothin' like moving a project on quickly, is there guys?
*People's Front of Judea, not the splitters at the JPF
Y'know, if I were Kaare Foy, Executive Chairman of Great Panther Silver (GPR.to) (GPL)...
...I'd spend less of my time trying to bully bloggers with empty threats of legal action that he'd never win because his case would be laughed out of court and more time worrying just why his company was performing like this compared to companies that he thinks are peers to GPR:
I'd also be more worried about just why his CEO seems more interested in cashing out his personal shareholding than actually running his company. After all, that job title of his does say Executive Chairman. Which means he's supposedly taking an active role at the company, right?
PS: Don't forget, Kaare:
Now you have a nice day, wontcha?
Labels: gpr.to, great panther
...gold, 5 minute candles:
WHEEEE! Isn't this fun?
What we know about Tom Mair of Golden Star (GSS) (GSC.to)
1) He's the President of Golden Star (GSC.to) (GSS)
2) He's the CEO of Golden Star
3) He's a bullshitter
Let's see what Mair was quoted as saying in this morning's production report NR:
"...third quarter gold production at Bogoso/Prestea was slightly higher than we had forecast. Wassa/HBB's gold production was slightly below expectation in the third quarter due to lower than expected mill availability and ore handling issues. On a consolidated basis, we achieved third quarter gold production guidance."
Waddya say about that, Owly?
To the numbers! In the same NR, we read that the Bogoso/Prestea mine saw 40,376 oz Au sold and the Wassa/HBB mine saw 33,485 oz Au sold. All fair enough until you compare those ounces again the REAL guidance supplied by GSS, back in its 2q11 MD&A published on August 9th. In that little work of abstract art we have the following:
Yep, both the GSS mines missed guidance, with the consolidated performance of 73,861 oz Au in 3q11 nearly ten thousand ounces short of the forecast of just ten weeks ago. So you achieved production guidance did you, Mair? MY ASS YOU DID! But oh, you're basing your crap on the September 14th production update NR when, just two freakin' weeks before the period closed you said Bogoso/Prestea would produce 39,000 oz and Wassa/HBB would produce 35,000 oz. And even then you missed! Here's a special message for you, bullshit merchant and your pisspoor gold mining joke company too:
Got it? Or do you need another visual to get the full picture here?
Notice anything, Tom?
In the latest episode of this occasional series that tries its very hardest to take the guff'n'nonsense written in junior mining news releases and convert it into English, we take in the NR from Takara Resources (TKK.v) published today.
This is what they wrote:
Press Release Source: Takara Resources Inc. On Monday October 17, 2011, 12:18 pm EDT
TORONTO, ONTARIO--(Marketwire -10/17/11)- Takara Resources Inc. ("Takara" or the "Company") (TSX-V: TKK.V - News) announces that over the past few months the Company has been working on data compilation of the Arakaka Gold Project, NW Guyana, South America, as well as following up on targets identified by the prior operators, which includes improving the access and infrastructure in furtherance of an extensive sampling, trenching and diamond drilling campaign. The area of the Arakaka Gold property has several historical open pits that have been mined since the early 1900's, and the results from the previous trenching, sampling and drill programs were very encouraging and require further exploration.
Takara commenced an extensive prospecting and geochemical survey program on the underexplored southwest and southeast parts of the Arakaka Gold Project. The program includes soil sampling, "ridge and spur" sampling and trenching. The geochemical survey is combined with reconnaissance mapping in order to evaluate geochemical anomalies and outline targets for further exploration. The main objective is to prepare for an extensive diamond drill program on the underexplored Macaw Gold trend, which will help the Company to evaluate the extent and degree of the gold mineralization and the exploration and mining potential of the Property. Macaw trend is well known for widely spread surface coarse grained gold and multiple artisanal workings. Soil samples have been taken at 50 meter intervals along survey lines and both the grab and soil samples are sent for preparation to Acme Analytical Laboratories Ltd. in Georgetown, Guyana. The samples are analyzed for fire assay and ICP analyses in Acme Analytical Labs in Santiago, Chile. The ACME analytical facilities in Santiago (Chile) and Vancouver (Canada), and the preparation facility in Georgetown (Guyana) are commercial geochemical analysis and assaying labs accredited under ISO 9001 certification.
The second area for a follow up is in the heart of the Arakaka Trend, in the vicinity of the Arakaka village. Despite the presence of the intensive alluvial mining in the area, the project remains largely underexplored. The area is characterized by gold bearing quartz-carbonate veins and veinlets with sulphide mineralization and disseminated gold mineralization in alteration zones, associated with faults and fold structures. Gold mineralization intersected by the previous drilling is associated with intense quartz veining and related alteration in the vicinity of a regional thrust fault, within a deformed metasedimentary package. The previous operator has identified two separate, high-grade quartz veins, both with coarse grained visible gold.
B-22 and B-23 Update
Title to two of the Company's properties, B-22 and B-23, within the Arakaka Gold Project is being challenged by a third party company. Takara has taken initial legal action in an effort to resolve the matter in its favour, and it intends to, where required, vigorously defend its position in this regard. Updates will be provided as additional information becomes available.
We don't have title to our property.
dyodd, dudettes and dudes
Can somebody ask The Motley Dumbass Christopher Barker about this chart, please?
After all, it is the chart of his "favourite silver miner" Great Panther (GPR.to) (GPL) that runs from the day he wrote those words (April 14th) to date.
Hey...only 40% down dude. Never mind, it's not as if you're actually responsible for your reader's losses, is it?
UPDATE: I'm sorry, did I say 40% down? Seems I meant 43.8% down (according to today's intraday action at least).
Peru import and export figures
I was hanging over at the Peru Central Bank website this morning...y'know, like you do...and got sidetracked by the monthly stats page for while. Then downloaded a whole bunch of numbers I like to follow but didn't really need today. Then before I could stop myself, generated two charts with pretty garish colours and everything so rather than waste them, I thought I'd stick them here.
This one shows how exports have evolved on a monthly basis since January 2000, with the columns split between mining and non-mining exports.
This one runs from 2005 (it was too busy to get in the whole dataset from 2000 onwards) and shows how exports have consistently outstripped imports in Peru. This (along with smart monetary policy form velarde & Co at the CenBank) is why the Peru Nuevo Sol (PEN) has been a strong currency recently.
So there you go.
Canaccord drops its gold and silver price forecasts
This thing The Can of Corn has with "peak gold" and "peak silver" (very silly names, dudes) has just got a bit less peaky, it seems. Los de la lata del choclo have just dropped their gold and silver price forecasts in the following way:
New Gold Forecasts: Our new gold estimates are as follows: US$1,576/oz (from US$1,575/oz) in 2011; US$1,750/oz (from US$1,650/oz) in 2012; US$1,650/oz (from US$1,500/oz) in 2013; and US$1,500/oz long term (2014 and beyond), from US$1,400/oz in 2014, US$1,300/oz in 2015, US$1,200/oz in 2016 and US$1,100 long term (2017 and beyond). Our peak gold price forecast remains unchanged at US$1,750/oz Au.
New Silver Forecasts: Our new silver estimates are as follows: US$35/oz (from US$39/oz) in 2011; US$40/oz (from US$41/oz) in 2012; US$33/oz (from US$35/oz) in 2013; and US$27.50/oz long-term (2014 and beyond), from US$31/oz in 2014; US$27/oz in 2015; US$24/oz in 2016; and US$22/oz long-term. Our peak silver price forecast has dropped to US$40/oz from US$45/oz previously.
This affects their covered miners of course and here's that little list of fun.
Timmins Gold Corp. (TMM : TSX-V): Show me the recovery; downgrading to SELL from Hold, with a revised target price of C$2.20 (from C$2.60)
Goldgroup Mining Inc. (GGA : TSX): Revised gold price deck; maintaining SPECULATIVE BUY rating with a revised target price of C$3.00 (from C$2.80)
Alexco Resource Corp. (AXR : TSX): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$9.75 (from C$12.25)
Bear Creek Mining Corp. (BCM : TSX-V): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$7.00 (from C$8.50)
Canaco Resources Inc. (CAN : TSX-V): Revised gold price deck; maintaining SPECULATIVE BUY rating with a revised target price of C$6.00 (from C$7.50)
East Asia Minerals Corp. (EAS : TSX-V): Unknown project timeline, higher risk aversion; maintaining HOLD but reducing target to C$1.75 from C$2.80
Exeter Resource Corp. (XRC : TSX): Sector risk adjustments impact valuation; reiterate SPECULATIVE BUY but lowering target to C$9.35 from C$11.50
Fortuna Silver Mines Inc. (FVI : TSX): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$8.25 (from C$9.00)
Golden Minerals Company (AUM : TSX): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$22.75 (from C$23.50)
MAG Silver Corp. (MAG : TSX): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$16.75 (from C$18.50)
North Country Gold Corp. (NCG : TSX-V): Market risk aversion impacts valuation; maintain SPECULATIVE BUY but reducing target to C$2.20 from C$2.70
Sandstorm Gold Ltd. (SSL : TSX-V): Revised gold price deck; maintaining SPECULATIVE BUY rating with a revised target price of C$1.70 (from C$1.90)
SilverCrest Mines Inc. (SVL : TSX-V): Revising peak silver forecast to US$40/oz, from US$45/oz; maintaining SPECULATIVE BUY rating with a revised target price of C$3.15 (from C$4.00)
Metals and Mining -- Precious Metals and Minerals: Record global liquidity should sustain robust precious metal prices; raising long-term gold/silver price forecasts to $1,500/$27.50 (from $1,100/$22)
Alamos Gold Inc. (AGI : TSX): Low cost production growth expected to continue; transferring coverage with a revised BUY rating and C$22.50 target price
La Mancha Resources Inc. (LMA : TSX): Revised gold price deck; growth, prospectivity & strong balance sheet; if only there was some liquidity! Maintain SPEC BUY and C$3.85 target
Minefinders Corporation Ltd. (MFN : AMEX): Banking on continued operational momentum and execution of growth plans; transferring coverage with a revised BUY rating and US$20.00 target price
Don't believe me on this? Well take a look yourself cos here's the report link. Please be having nice yes day yes thanks you very welling.
...copper, hourly candles.
Because it's definitely the metal I most care about today. And it's my blog. So there.
remember different
IKN128 has just been sent to subscribers and though hardly Pulitzer material it's better than last week's load of junk.
thinking about OWS...
...got me playing Manu Chao this morning. And this track is just wonderful.
Mike Churchill on OWS
Main man Michael Churchill of Churchill Research sent the following out to his mailing list today. As it's cool to pass on, that's exactly what I'm doing here. enjoy.
Classical Insights Afternoon Bullet Points October 16, 2011
I went to Zuccotti Park yesterday and talked with about 20 of the Occupy Wall Street protesters. Everyone was polite and happy to chat. I'd say the breakdown between good and bad ideas was a little better than 50/50. Yet the protestors' core notion -- that average Americans are being screwed by the powers that be -- has plenty of merit. On specific points, the Occupy Wall Street people and the Tea Partiers actually have a fair amount in common.
Here are some of the individual protestors' ideas:
Replace the existing 535-man congress with direct democracy -- thereby cutting down on corruption. The guy proposing this was in his 20s and carried a sign reading "Waterboard Wall Street." He was quite eloquent, arguing that today we have the technology to allow all Americans to vote on major decisions, so why not do it? It's a reasonable point. In fact, author Eric Morse made a similar argument in his recent book Juggernaut. Morse recommends we move to a 10,000-man congress, thereby returning us to the original, 1790s-era ratio of 30,000 citizens per congressperson. This approach would cut down on corruption because 30,000 people are too many to bribe.
"Weak Messianism." I chatted for a while with a scholarly looking fellow in his late 20s at a table with a couple of books by philosopher Walter Benjamin. The concept behind weak messianism is that small powerless movements can have an inordinately large impact because they embody the sins and problems of the recent past, bringing them into the open and helping to get them resolved. Apparently, this notion has roots in Eastern Orthodox philosophy. "Are there dirty hippies here? Yes," said the fellow at the table. "Are there people doing drugs here? Yes. But this is all part of the process. It's a mistake to try to define the goals of the movement too quickly." The process of airing all the grievances and concerns is itself useful, he said. "The protest has actually morphed several times since it started a few weeks ago."
Stop the foreign wars and use those resources here at home. This was a big theme. Many protestors are very upset that we're spending hundreds of billions of dollars fighting wars all over the world when our own economy is weak and jobs are hard to find. I was handed a flyer from an outfit called "Veterans for Peace" which contained several noteworthy statistics:
The U.S. military budget is 7x that of China ;
New Yorkers have paid $113 billion for the wars in Afghanistan and Iraq over the past 10 years. For that same money, 19 million students could get scholarships to go to college for one year;
$1 billion spent on the military creates 8,500 jobs, whereas $1 billion in tax cuts generates 10,800 jobs. (Not sure about that point but it's interesting they supplied it.)
End the Fed. A saw one big sign making the case that the Federal Reserve is a non-governmental entity whose primary goal is to empower and enrich bankers, not individuals. It's a fair point. As G. Edward Griffin wrote in The Creature from Jekyll Island, our current banking system is designed to implode periodically – and for the losses to be socialized when it does. The protesters are rightfully mad about this, though as a practical matter most probably don't understand the nuts and bolts of it. They simply see that Wall Street banks blew up, taxpayers bailed them out, nobody went to jail, and the bigwigs made millions of dollars. It doesn't seem right to them. On this issue the protests (as well as the Tea Party protests) should have some impact. We can expect some combination of higher capital requirements and lower tolerance for high-risk trading activities by banks going forward.
"Aggregate demand is too weak." This was written on a sign carried by a fellow wearing an "MMT" baseball cap. In this case, MMT stands for Modern Monetary Theory. The protester argued that the government needs to increase spending drastically to boost the economy. I disagreed with him on that point, proposing that a combination of tax cuts and nominal GDP targeting via quantitative easing would make more sense. He disagreed and we argued the point for a while. There was another economist type standing next to him (also an MMT-er), who agreed that tax cuts would be an acceptable way to boost aggregate demand.
College is way overpriced and the education is lousy. One of the most interesting conversations I had was with a chunky 22-year-old from Vermont who is $250,000 in debt yet still doesn't have his bachelor's degree. He was carrying a sign that read, "Where's our Robin Hood?" He has attended Hofstra, University of Vermont and (currently) Ramapo College in New Jersey . His degree is costing him about $50,000 per year and he expects to need 5 years to graduate. After graduation he wants to get a master's degree, at which point he expects to be $500,000 in debt. He is studying business and his goal is to work in the music business for a few years and then start a record company.
"Nobody will take you seriously if you don't have a college degree," he explained. "You can't get a job, and a bank won't give you a business start-up loan." He said he doesn't think any of the schools he's attended has given him a good education. "I'm sitting in computing classes and they're teaching us how to use Excel and Powerpoint – things I learned when I was 16. I'm sitting there thinking that I'm paying thousands of dollars for this." He said his student loans carry a 7% interest rate.
Another guy (with a clearly skeptical bent) joined the conversation and asked, "So why don't you just go to a cheaper school?" The Vermonter responded that he wanted to get out of Vermont and see new things.
Workers of the World Unite! I chatted with a full-on socialist who argued for nationalization of banks and industries. Such a move would free workers from mind-numbing jobs -- while bringing an end to the capitalist practice of skimming the excess value created by laborers. I argued that a successful business can't function on labor alone, and that without a visionary running the business labor won't create any excess value at all. He rejected this notion, arguing that people are motivated to work and create by non-monetary impulses. The engineers at Apple Computer, for instance, would be inspired to do their work even without the profit motive.
Socialists or communists were manning four tables in various parts of the park. Nearly all were older guys. I don't think they'll get much traction with the young protestors. For instance, the socialist I talked to cited steel-mill work as an example of a particularly mind-deadening task. Yet most steel mill jobs have been computerized for decades and some are fairly high tech at this point. Smart young people just aren't going to buy into these old socialists' vision. The weakness of their sales pitch is magnified by the fact that much of America 's wealth is now intellectual rather than physical -- and intellectual property can't be effectively nationalized in the first place.
There's another issue that rankles down here: CEOs making millions while they downsize their labor forces and move factories to China . That just doesn't strike people as right. In some cosmic way they have a point, which goes back to the whole notion that man, for most of his history, lived in egalitarian hunter-gatherer tribes. As such, when a few people get super-rich by firing others, it just doesn't sit well. That's an emotionally live issue and one that's not going away.
Who are the 1% that these protestors are so mad at? My sense is that the 1% does not refer to successful people generally, but rather to those few who get rich via collusion between government and business. For instance, defense contractors greasing palms of congressmen would fall into this category, as would bankers who receive billions in bailouts. I'm reminded here of Amity Schlaes' concept of "the Forgotten Man," which dates back to the 1930s: When A makes a deal with B, the loser is very often C, who is not even at the table. The Occupy Wall Street people are "C"s to a man. They know this, they are not happy about it – and they have a point. The Tea Partiers also are mostly "Cs," so I don't think it's a coincidence that I saw some Ron Paul signs at Zuccotti Park .
I saw a baby wearing a T-shirt that read, "Still waiting for the Great Leap Forward." I said to the mother, "Um, I'm not sure if you know this, but the Great Leap Forward was a socialist experiment in China in the 1950s that went horribly wrong and killed millions of people." She said she didn't know that and had actually gotten the phrase from a Billy Bragg song. A few others nearby also were wearing T-shirts with slogans on them. They'd never heard of China 's Great Leap Forward, either, and all said they would look it up on Wikipedia when they got home.
End hydraulic fracturing. There were several people around the park with signs calling for an end to fracking, arguing that it poisons groundwater. I am open to convincing either way on this one. I've read articles suggesting both sides have a case.
A number of people were carrying signs saying "Tax the Rich" or some variant thereof. I didn't strike up conversations with any of them, on the assumption they wouldn't have much interesting to say. Still, "Tax the Rich," is clearly a popular theme now, even among many Republican voters. No wonder Mitt Romney is not proposing cuts to income-tax rates for higher-income Americans.
Big groups of people were engaged in drum-pounding, chanting, and call-and-response sessions at opposite ends of the park. After I left, I realized that I'd simply blotted them out, probably on the unconscious assumption they were all idiots. Later on, though, it occurred to me that these people likely were the real occupiers – i.e. the ones sleeping out in the park every night. It also occurred to me that many of the people I talked to probably were just down there during the days.
Later Saturday evening, some of the occupiers moved to Times Square and created a real mess. I was walking down 7th Avenue trying to catch a train at Penn Station when the cops shut down a couple of blocks. That cost me 10 minutes of extra walking and I almost missed my train. My empathy for the protestors declined substantially at that point. When protests start inconveniencing regular people just trying to walk down the street, you're into Third World territory. The cops were everywhere around Times Square but just focused on directing traffic and channeling the people flow.
Feel free to forward this as there are no investment themes contained.
Mike Churchill
Bullets are archived at www.churchillresearch.com .
Ollanta Humala's approval rating, 100 days in
We're just a hop and a skip from Ollanta Humala's first 100 days as President of Peru, so today's Ipsos/Apoyo approval rating will mark his popularity at that stage. Here's the chart...
...which shows today's 62% approval rating (margin of error +/-2.8%) as well as the 65% he scored this time last month, so perhaps the beginnings of a deterioration in his honeymoon numbers showing through. But all the same, 60%+ in Peru is a strong showing for a President of any stripe at any time, so I'm sure he's not sweating that 3%. When asked why they approved, the main reasons given were that he's making good on his election promises, he cares for the poor and he's pushing for investment in the country. Let's hope those continue. Data from here
update: nice to see people long the scam stock st elias mines coming over to visit.
Labels: ollanta humala
After catching up with the market action and week'...
A quick update on Jaguar (JAG) (JAG.to) before hea...
Jaguar Mining (JAG) (JAG.to): Tristeza não tem fim...
The "Junior Mining News Release Guffaw of the Day"...
Y'know, if I were Kaare Foy, Executive Chairman of...
What we know about Tom Mair of Golden Star (GSS) (...
Can somebody ask The Motley Dumbass Christopher Ba...
Canaccord drops its gold and silver price forecast...